Core Insights - Hims & Hers Health's stock surged over 16% after announcing its entry into a new specialty focused on perimenopause and menopause care for women, outperforming the S&P 500's 0.4% increase [1][2]. Group 1: New Market Segment - The company is launching a new specialty centered around perimenopause and menopause care, offering customized treatment plans based on individual patient history and preferences [2][3]. - Management identified a significant gap in healthcare options for women, targeting an addressable market of approximately 1.3 million females in the U.S. [3]. Group 2: Patient Empowerment - Hims & Hers aims to provide women with more choices in healthcare, addressing the outdated systems that have historically underserved them [3]. - Eligible patients will have access to prescription medications in various forms as part of the new offering [4].